Research out of the UK has found that one of the many compunds in cannabis can treat epilepsy with astounding results.
Researchers treated mice and rats with epilebsy with Cannabidivarin (CBDV), and found it strongly controled seizures without creating the shaking or other side effects of traditional epilipsy drugs.
The research was carried out by University of Reading and GW Pharma, (article here ) whose other cannabis product, an oral cannabis spray (Sativex) is approved worldwide for numerous other uses. Well, worldwide- EXCEPT for in the US. Where despite the US government holding patents on medicinal uses of Cannabis, and despite 17 states and the district of columbia recognizing medicinal use of marijuana, the federal government still classifies it as Schedule I- meaning no recognized medicinal use.
Amazingly, currently in the US it is easier to get approval for medicinal research with MDMA, the drug more commonly known as “Ecstasy”, then it is for marijuana.
While “THC” is the compound in cannabis most are familiar with (and the one years of breeding for recreational use has focused on) there are many other compounds in cannabis increasingly being recognized for their medicinal properties. Compounds which have nothing to do with “getting high”.
And thanks to the continuation of prohibitions on research, and a government monopoly on the supply of cannabis for research, the US medical industry is falling far behind the rest of the world in capitalizing on these products. And falling behind in easing the pain and suffering of countless individuals- due to nothing more then an ignorant adherence to disproven lies.